These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6240265)

  • 1. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
    Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
    Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
    Lehmann W; Widmaier R; Langen P
    Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of chalone action.
    Lehmann W; Graetz H; Schunck H; Schütt M; Langen P
    Acta Histochem Suppl; 1983; 27():63-71. PubMed ID: 6223337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Böhmer FD; Lehmann W; Schmidt HE; Langen P; Grosse R
    Exp Cell Res; 1984 Feb; 150(2):466-76. PubMed ID: 6363109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a chalone-like inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Lehmann W; Samtleben R; Graetz H; Langen P
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):101-7. PubMed ID: 6221930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W; Graetz H; Schütt M; Langen P
    Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of membrane-associated growth inhibitor activity for Ehrlich ascites mammary carcinoma cells.
    Herrmann I; Grosse R
    Biomed Biochim Acta; 1986; 45(4):447-57. PubMed ID: 3010958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adenosine and epidermal growth factor on the growth of mouse mammary epithelial cells.
    Yuh IS; Jang BB; Hong BJ
    Cell Biol Int; 1998; 22(2):131-5. PubMed ID: 9878100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth effect of lithium on mouse mammary epithelial cells in serum-free collagen gel culture.
    Tomooka Y; Imagawa W; Nandi S; Bern HA
    J Cell Physiol; 1983 Dec; 117(3):290-6. PubMed ID: 6317698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ehrlich ascites cell (EAC) chalone assay using purified calf thymus-DNA polymerase alpha.
    Nakai GS; Gergely H
    Biomedicine; 1980 Nov; 33(7):208-9. PubMed ID: 6452912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of adrenaline on the mitosis-inhibiting action of a chalone-containing preparation in Ehrlich ascites tumor].
    Romanov IuA; Ivchenko TN; Sultanova ZF
    Biull Eksp Biol Med; 1988 Mar; 105(3):345-7. PubMed ID: 2964881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors in mouse mammary cell interactions in vitro.
    Miller FR; Bukowski J
    Anticancer Res; 1994; 14(5A):2033-8. PubMed ID: 7847846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
    Zwiebel JA; Davis MR; Kohn E; Salomon DS; Kidwell WR
    Cancer Res; 1982 Dec; 42(12):5117-25. PubMed ID: 6291748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.
    Peterson G; Barnes S
    Cell Growth Differ; 1996 Oct; 7(10):1345-51. PubMed ID: 8891338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation-associated increase in sensitivity of mammary epithelial cells to inositol-1,4,5-trisphosphate.
    Enomoto K; Furuya K; Yamagishi S; Maeno T
    Cell Biochem Funct; 1993 Mar; 11(1):55-62. PubMed ID: 8453737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I, EGF, and sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway.
    Sobolewska A; Gajewska M; Zarzyńska J; Gajkowska B; Motyl T
    Eur J Cell Biol; 2009 Feb; 88(2):117-30. PubMed ID: 19013662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.